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Abstract
Background One strategy to reduce the consumption of
resources associated to specific procedures is to utilize
clinical pathways, in which surgical care is standardized
and preset by determination of perioperative in-hospital
processes. The aim of this prospective study was to
establish the impact of clinical pathways on costs, compli-
cation rates, and nursing activities.
Method Data was prospectively collected for 171 consec-
utive patients undergoing laparoscopic cholecystectomy
(n = 50), open herniorrhaphy (n = 56), and laparoscopic
Roux-en-Y gastric bypass (n = 65).
Results Clinical pathways reduced the postoperative hospi-
tal stay by 28% from a mean of 6.1 to 4.4 days (p<0.001),
while the 30-day readmission rate remained unchanged
(0.5% vs. 0.45%). Total mean costs per case were reduced
by 25% from € 6,390 to € 4,800 (p<0.001). Costs for
diagnostic tests were reduced by 33% (p<0.001). Nursing
hours decreased, reducing nursing costs by 24% from €
1,810 to € 1,374 (p<0.001). A trend was noted for lower
postoperative complication rates in the clinical pathway
group (7% vs. 14%, p = 0.07).
Conclusions This study demonstrates clinically and eco-
nomically relevant benefits for the utilization of clinical
pathways with a reduction in use of all resource types,
without any negative impact on the rate of complications or
re-hospitalization.
Keywords Clinical pathways . Cost reduction . Surgery
Introduction
Costs in health care systems are rising every year, reaching
€ 35.3 billion (euro) in Switzerland for the year 2005 or
11.6% of the gross domestic product and are estimated to
reach € 36.6 billion in 2007. This is the second largest
amount spent in countries of the Organisation for Economic
Cooperation and Development after the USA, which spends
15.3% of its gross domestic product for the health system.
Other countries spent similar proportions (UK 8.3%, France
10.5%, and Germany 10.9%). In Switzerland, € 12.3
billion, or 35% of total health care costs, were generated
by hospitals [1]. This figure is similar to other countries,
e.g., in the US [2]. It should be noted that surgical
departments are responsible for about a third of all hospital
costs.
Because rationalization efforts to reduce costs are
problematic and reluctantly accepted by the public, other
approaches are needed. An acceptable strategy incorporates
the reduction of costs without loss of quality. Costs and
consumption of resources in hospitals can be reduced by
optimization of in-hospital processes. With clinical path-
ways, also called critical pathways or care maps, surgical
care is standardized and preset by determination of
perioperative in-hospital processes.
Benefits related to clinical pathways have been shown in
some conditions treated by internists [3–5]. In surgery, the
impact of clinical pathways on resource utilization remains
unclear. A few studies are available, but are restricted to a
single procedure, and cost analyses are mainly based on the
length of hospital stay [6–15] (see Table 4). Most studies
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come from the US [16] and two thirds of studies on clinical
pathways were classified as of low quality [17]. Notably,
the issue of safety related to preset simplified flow sheets
has not been addressed. Moreover, no data is available on
the impact on nursing activities.
Therefore, we designed a prospective study to investi-
gate the impact of clinical pathways on a variety of
clinically relevant parameters, including utilization of a
variety of resources and costs. Complications were ana-
lyzed using a standardized validated grading system [18].
The nursing activities were assessed in 12 categories and
measured in hours of work. A cohort study type using a
control group of similar patients treated just before the
introduction of the clinical pathways was chosen.
Methods
Study design
To assess the impact of clinical pathways at a major
surgical university teaching hospital with a broad spectrum
of abdominal procedures, we selected one routine open
(hernia repair) and one routine laparoscopic procedure
(cholecystectomy) as well as a more complex laparoscopic
operation (Roux-en-Y gastric bypass). After the introduc-
tion of clinical pathways, the study patients were prospec-
tively registered. This data was compared to a control group
of patients treated without clinical pathways.
Implementation of clinical pathways
Clinical pathways were developed in cooperation with all
staff surgeons and nurses of the Department for Visceral
and Transplantation Surgery, University Hospital Zurich.
The clinical pathways consisted of standardized order
forms presetting fluid management, nutrition, analgesia,
reserve medications, preoperative examinations, detailed
laboratory blood testing, and planned discharge (Fig. 1).
In addition, a separate document providing clear guide-
lines and specific explanations for the doctors, the nurses,
and the patients was made available. All patients received
information on in-hospital care, planned time of discharge,
and recovery time in the outpatient clinic prior to
hospitalization.
Study population
After an introduction phase of 2 months, each consecutive
patient undergoing the abovementioned procedures was
prospectively enrolled in the study during a 6-month
period. Fifty laparoscopic cholecystectomies, 56 open
hernia repairs, and 65 laparoscopic Roux-en-Y gastric
bypasses were performed during the study period. The
study patients were compared to a control group which
underwent the same procedures during a 1-year period prior
to the introduction of the clinical pathways. This control
group consisted of 106 laparoscopic cholecystectomies, 103
open hernia repairs, and 105 laparoscopic gastric bypass
procedures in which data were collected prospectively. The
exact period of data collection was only known to the
involved investigators.
Study endpoints and cost calculation
The primary study endpoints were chosen with respect to
the targeted impact of the clinical pathways, which were
costs of medical examinations and hospital stay. The
amount of laboratory tests, X-ray examinations, and other
additional examinations was assessed and multiplied by the
respective costs of each test. Length of hospital stay was
multiplied by the actual costs for the room and catering per
day, generating infrastructure costs.
Costs for the surgical procedure itself (operation and
anesthesia) were not analyzed because the clinical pathways
were not designed to influence them.
To evaluate the safety of clinical pathways, severity of
in-hospital complications was stratified using a validated,
therapy-orientated classification system [18].
Nursing hours
Nursing activities were recorded by the nursing staff for every
patient grouped into 12 categories and measured in hours:
mutation (check in/out; transfer to another ward, X-ray
department, etc.), mobilization, body care, eating/drinking,
sanitation, dialogue with the patient, documentation, dialogue
with co-workers, surveillance, blood sampling, medication,
and treatment (wound dressings, management of iv lines, and
so on). Total nursing hours as well as nursing hours per day
were recorded to compare the direct influence on nursing
intensity. For cost calculations, one nursing hour was
equivalent to € 61.9 according to the hospital policy.
Sample size calculation and statistical analysis
Data of a pilot study group without clinical pathways and the
theoretical values for the ideal patient following strictly a
clinical pathway were entered in a power calculation. As a
result, the differences for costs of examinations and hospital
stay were 39% and 33% for cholecystectomies, 30% and 18%
for hernia repairs, and 54% and 40% for gastric bypass,
respectively.With a power of 90% (1 − β) and a type I error α
of 5% the calculated sample sizes resulted in 45 cholecys-
tectomies, 55 hernia repairs, and 27 bypass operations.
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Fig. 1 Clinical pathway as in use for laparoscopic gastric bypass (example) with room for individual adjustments
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Statistical analysis was performed using standard soft-
ware SPSS 11.0 for Windows (SPSS, Chicago, Illinois,
USA). To compare continuous variables between the
groups, the Mann–Whitney U test was used. Dichotomous
variables were compared using the chi-square test or when
appropriate, Fischer’s exact test was applied. Results are
expressed as means and standard deviation unless otherwise
stated. A p-value of less than 0.05 was considered to
indicate statistical significance.
Results
Overall, 171 patients treated according to clinical pathways
were compared to 314 patients treated prior to the
implementation of clinical pathways. The two groups were
comparable regarding age, 46.2 vs. 47.3 years (p = 0.6),
mean ASA 2.09 vs. 2.07 (p = 0.7) as well as gender
distribution, 47 vs. 54% female patients (p = 0.09).
How did clinical pathways reduce the use of perioperative
examinations?
No difference could be observed for the amount of preoper-
ative chest X-rays performed in the two groups, but unneces-
sary ECG and respiratory function testing were significantly
reduced by 30% (p<0.001) and 63% (p<0.001), respectively.
The number of blood tests also decreased significantly,
reducing costs of hematograms by 26% (p = 0.002) and
blood chemistry by 34% (p<0.001) (Table 1).
Did clinical pathways influence morbidity?
In-hospital complications occurred in 11% of all patients.
There was no significant difference regarding complication
rates in the clinical pathway group (7% vs. 14%, p = 0.07).
The severity of complications did not change with the
introduction of clinical pathways (Table 2).
How did clinical pathways influence nursing activities?
The recorded total nursing hours decreased for all patients
from 29.2 to 22.2 h by 24% (p<0.001), an effect partially
accountable to the shortened hospital stay. The total nursing
hours per patient and day did not change significantly, from
3.8 to 3.67 h, or −3.5% (p = 0.213). However, after the
introduction of clinical pathways, nurses recorded more
time for the dialogue with the individual patient, which
increased by 34% (p<0.001). Additionally, more time
(+5.1%) was used for documentation, whereas less time
was spent performing the duties in most of the other
nursing categories (Fig. 2).
How was the compliance to clinical pathways in all
patients?
To evaluate the compliance with the clinical pathways, the
number of patients who strictly followed their predicted
course in respect to hospital stay was analyzed. Patients had
a hospital stay of precisely or less than the proposed value
after gastric bypass in 69%, after cholecystectomy in 70%,
and after hernia repair in 86%.
How did clinical pathways impact hospital stay and costs?
The mean length of hospital stay decreased from 7.6 to
5.8 days (23%) using clinical pathways (p<0.001); the
postoperative length of stay was shortened by 28% (p<
0.001). The readmission rate within 30 days after discharge
was unchanged (0.5% vs. 0.45%).
Table 1 Effect on periopera-
tive examinations used in all
patients
Values are means (standard
deviation). Various tests:
computed tomography, mag-
netic resonance tomography,
scintigraphy
ECG electrocardiogram, €
euros
Without clinical pathway With clinical pathway Change % p
n 314 171
Numbers of tests per patient
Chest X-ray (n) 1.3 (1.3) 1.2 (0.9) −11.3 0.644
Plain abdominal film (n) 0.1 (0.3) 0.0 (0.2) −50.0 0.129
Abdominal ultrasound (n) 0.2 (0.5) 0.1 (0.3) −68.4 0.001
ECG (n) 0.9 (0.6) 0.6 (0.5) −30.4 <0.001
Respiratory function (n) 0.3 (0.5) 0.1 (0.3) −62.5 <0.001
Ergometry (n) 0.1 (0.3) 0.0 (0.0) −100.0 0.001
Costs of tests per patient
Hematogram (€) 59.6 (60.1) 44.5 (34.6) −25.5 0.002
Blood chemistry (€) 287.4 (243.3) 189.3 (163.7) −34.1 <0.001
Urine lab (€) 1.6 (4.2) 1.1 (3.2) −33.3 0.096
Microbiology (€) 16.0 (60.8) 4.7 (18.7) −70.4 0.196
Various test (€) 120.2 (474.1) 25.1 (182.5) −79.1 0.012
34 Langenbecks Arch Surg (2009) 394:31–39
Overall, the total costs for all examinations per patient
were reduced by 33% from € 1,097 to € 739 (p<0.001).
Total infrastructure costs decreased by 23% from a mean of
€ 3,483 to € 2,687 (p<0.001). Nursing cost decreased by
24% from € 1,810 to € 1,374 (p<0.001).
Total mean costs per case were reduced by 25% from €
6,390 to € 4,800 (p<0.001); Table 3.
How did clinical pathways impact the different surgical
procedures?
For the laparoscopic cholecystectomy, the postoperative
length of stay was shortened by 24% whereas total costs of
all examinations decreased significantly by 44%; the
corresponding figures for hernia repairs were 34% and
53% and for laparoscopic gastric bypass 32% and 27%,
respectively. Overall mean total costs per laparoscopic
cholecystectomy were reduced by 24% from € 5,092 to €
3,879 (p<0.001); for hernia repairs by 30% from € 3,906 to
€ 2,722 (p<0.001); for laparoscopic gastric bypass by 28%
from € 10,132 to € 7,296 (p<0.001); Table 3.
Discussion
This study was designed to evaluate the impact of clinical
pathways on cost saving, nursing activities, and postoper-
ative morbidity on three elective general surgery proce-
dures. This study demonstrates a positive impact on all
examined endpoints. The length of hospital stay, as well as
number of examinations, was significantly reduced without
a negative impact of increased morbidity, which under-
scores the safety of the routine use of clinical pathways.
The nursing hours decreased significantly and the pattern of
nursing activities shifted, allowing nurses more time for a
dialogue with patients. As a consequence, total costs,
Fig. 2 Change of nursing hours per patient and day. The effects on
nursing activities show a significant reduction in most physical
activities and a highly significant increase of time spent for the
dialogue with the patient (values with * were not significant)
Table 2 Morbidity
Degree of
complication
Without clinical
pathway
With clinical
pathway
n 314 171
None 268 (85%) 159 (93%)
I 30 (6%) 8 (5%)
II 5 (2%) 2 (1%)
IIIa 4 (1%) 0
IIIb 7 (2%) 1 (1%)
IVa 0 1 (1%)
IVb 0 0
V 0 0
Values are number of patients (%). There was no significant difference in
the distribution of complications between groups (p=0.074; chi-square
test). Grade I: any deviation from the normal postoperative course without
the need for pharmacological treatment or surgical, endoscopic, or
radiological interventions; grade II: requiring pharmacological treatment;
grade III: requiring surgical, endoscopic, or radiological interventions
either not under general anesthesia IIIa or under general anesthesia IIIb;
grade IV: requiring ICU treatment either for single organ dysfunction IVa
or multiorgan dysfunction IVb; grade V: death of a patient [18]
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including costs for examinations, infrastructure costs, and
nursing costs, were dramatically reduced.
Health care costs are rising throughout western health
systems [19, 20] and pressure is increasing from govern-
ments and insurance institutions to attain an “economic”
utilization of medical resources with the aim to lower
expenses. On the other hand, the patient population is
growing older with an increasing incidence of comorbid-
ities. Thusly, treatment options are becoming more diver-
sified and more expensive. This area of conflict may leave
only a small scope for improvements in the daily practice
[21].
One possibility of improvement is the optimization of in-
hospital processes. Clinical pathways, which originate from
evidence-based guidelines, are designed to standardize and
optimize the current practice. The length of hospital stay is
defined and unnecessary investigations are omitted. Addi-
tionally, this treatment plan is available for all health care
professionals and the patient can be orientated well in
advance facilitating the organization of the post-hospital
recovery period. Thus, clinical pathways have the potential
to save resources.
The available surgical literature on clinical pathways in
Europe is sparse [11, 16]. Most studies are focusing on one
single operation and on length of hospital stay [6–15]
(Table 4). Costs were only analyzed with the help of
general model calculations and resource utilization was not
analyzed in detail [22–24]. All these studies found a
reduction of hospital stay ranging between 14% and 46%
as well as cost savings up to 47%. Other surveys from
nursing institutions have described the use of clinical
pathways, but no data was presented [25–28]. A systematic
review by El Baz found that 91.3% of all studies on clinical
pathways were retrospective, 59% adopted parametric
statistical test, and overall 67% were classified as of low
quality [17]. In the current study, we calculated detailed
costs based on the used resources. The data collection was
done prospectively and statistical analyses were made with
non-parametric tests. We could show that not only the use
of diagnostic tests could be decreased, with an associated
decrease of costs by 33%, but also the length of the hospital
stay, therefore reducing infrastructure costs by 23%. This
resulted in a total cost reduction of 25%.
The savings effect of clinical pathways was considerably
related to the reduction of the length of hospital stay. There
are different reasons accounting for this effect. First, with
clinical pathways, residents had clear guidelines when to
discharge patients. Hence, individual variability of dis-
charge policy was limited. Second, the day of discharge
was already known to the hospital staff and, most
Table 3 Effect on hospital stay and costs
Without clinical pathway With clinical pathway Change % p
Cholecystectomy (n) 106 50
Hospital stay (days) 6.0 (2.8) 5.1 (2.4) −15.4 0.006
Postoperative hospital stay (days) 4.8 (2.5) 3.7 (2.0) −23.6 <0.001
Costs of all tests (€) 880 (864) 489 (330) −44.4 <0.001
Infrastructure costs (€) 2,772 (1,304) 2,346 (1,116) −15.4 0.006
Nursing costs (€) 1,440 (988) 1,044 (1,077) −27.7 <0.001
Hernia repair (n) 103 56
Hospital stay (days) 4.9 (2.8) 3.7 (1.4) −24.4 <0.001
Postoperative hospital stay (days) 4 (2.6) 2.6 (1.3) −34.2 <0.001
Costs of all tests (€) 564 (438) 265 (186) −53.0 <0.001
Infrastructure costs (€) 2,238 (1268) 1,692 (644) −24.4 <0.001
Nursing costs (€) 1,104 (867) 765 (320) −30.6 0.002
Gastric bypass (n) 105 65
Hospital stay (days) 11.8 (5.4) 8.3 (2.0) −29.7 <0.001
Postoperative hospital stay (days) 9.4 (4.8) 6.4 (1.6) −31.6 <0.001
Costs of all tests (€) 1,838 (1,135) 1,339 (460) −27.1 <0.001
Infrastructure costs (€) 5,418 (2493) 3,807 (910) −29.7 <0.001
Nursing costs (€) 2,876 (1,288) 2,150 (648) −25.2 <0.001
All patients (n) 314 171
Hospital stay (days) 7.6 (4.9) 5.8 (2.8) −22.8 <0.001
Postoperative hospital stay (days) 6.1 (4.2) 4.4 (2.3) −27.9 <0.001
Costs of all tests (€) 1,097 (1,018) 739 (594) −32.6 <0.001
Infrastructure costs (€) 3,483 (2,258) 2,687 (1,283) −22.8 <0.001
Nursing costs (€) 1,810 (1,312) 1,374 (954) −24.1 <0.001
Total costs (€) 6,390 (4,355) 4,800 (2,636) −24.9 <0.001
Values are means (standard deviation)
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importantly, to the patient at admission facilitating accep-
tance for discharge as both the patient and his relatives were
prepared. However, the average length of hospitalization in
Switzerland is still longer than in some other countries, for
example 12.8 days vs. 7.0 days in the US [29]. This is
connected to different factors related to the available health
care system (e.g., low percentage of same day admissions
and operations) and cultural issues. Nevertheless, clinical
pathways can provide a first step in reducing length of stay,
and thereby saving costs.
In this study, hernia repairs were not done ambulatorily.
Indeed, hernia repairs can be done in an ambulatory setting.
There are several reasons why, in this hospital, this is not
the case. First, this is a tertiary referral center and patients
with more complicated diseases (recurrences) and more
comorbidities (patients under anticoagulation, immunosup-
pression, cardiovascular diseases, etc.) are referred. Second,
patients in the hernia repair group are older than the other
groups (median 60 years) and many older patients are
reluctant to early discharge because they lack care at home.
Third, this hospital, at the time of the study, did not offer
same day admissions for organizational reasons as anesthe-
tists did not see patients in the outpatient setting. Thus, 46%
of the savings effect in hernia repair was related to the
shortening of the hospital stay, whereas 25% were related to
reduction of test used.
When using preset order forms, like in clinical pathways,
the threat of uncritical adoption by residents is eminent; this
could have an impact on safety issues. The impact on patients’
safety is not directly measurable because adequate tests are
lacking. For example, it cannot be predicted how an omitted
measurement of a C-reactive protein level can delay a timely
diagnosis and treatment of a possible complication, and there-
fore obviate a potentially hazardous course of the hospitali-
zation. The lack of standardized measurement of morbidity
also prevents conclusive comparisons among groups of
patients [30]. Most important in this study, using a recent
morbidity scale system [18], we could show that clinical
pathways had no measurable negative influence on the
patients’ safety. Furthermore, readmission rates were similar
between patients treated with or without clinical pathways.
An advantage of clinical pathways is the integration of
the latest recommendations of medical societies into the
preoperative patient management in respect of anesthesiol-
ogy [31] or cardiology [32]. This assures that preoperative
tests, such as chest X-rays or blood analyses, are done only
according to state-of-the-art recommendations. The use of
clinical pathways is also very helpful for teaching purposes,
especially for residents in training. However, the residents’
fear of blind automatisms (“cookbook medicine”) has to be
taken seriously. It is crucial that senior surgeons maintain
their teaching and supervising function because clinical
pathways can certainly not replace the surgical education
[33].
The compliance rate with the clinical pathways in this
study was 75%, which is higher than in other reports (66%)
[11]. This was partially accountable to the fact that all key
users, doctors, and nurses were involved in the design and
implementation of the clinical pathways, an effect that was
also confirmed in another study [34]. Clinical pathways
have often been introduced and assessed by nursing
professionals and doctors were blamed “to be slow to buy
in” [28]. If the costs of their practices are well displayed,
doctors and nurses can be easily convinced to change their
clinical practice [35]. However, to keep in compliance with
clinical pathways, an increased amount of ongoing educa-
tion [33, 36] and re-evaluation has to be guaranteed. In a
recent study, the implementation of clinical pathways in
combination with continuous education led to a 3.5-fold
reduction of inappropriate prescription of medications [4].
Table 4 Literature on the appliance of clinical pathways in surgery
Author (year) Appliance in n Reduction of
cost (%)
Reduction of
hospital stay (%)
Safety
Archer et al. (1997) [6] Colectomy 24 17% 27%
Pritts et al. (1999) [7] Bowel resection 337 30% 25% Equal
Porter et al. (2000) [8] Pancreaticoduodenectomy 148 23% 17% Equal
Melbert et al. (2002) [9] Colon resections 385 24% 30%
Huerta et al. (2001) [10] Gastric bypass 364 40% 20% Equal
Soria et al. (2005) [11] Laparoscopic cholecystectomy 300 14% 32% Equal
Tan et al. (2005) [12] Colorectal surgery 408 14% Equal
Murphy et al. (2007) [13] Aortic aneurysm repair 60 44%
Kennedy et al. (2007) [14] Pancreaticoduodenectomy 135 47% 46%
Kariv et al. (2007) [15] Colectomy 196 15% 20% Equal
This study Visceral surgery 485 25% 23% Equal
All studies were cohort studies with historical controls, except Melbert et al. with two concurrent comparison groups. No study assessed nursing
activities, which were significantly changed in this study
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Nursing work hours have never been analyzed in
combination with the use of clinical pathways. The total
nursing hours per patient for the three analyzed operations
decreased in the study population, whereas the mean
nursing hours per patient increased for other operations in
the same hospital. Interestingly, the pattern of activities
shifted to 35% providing more time for dialogue with the
patient whilst saving time in other activities such as
transporting or accompanying the patient to the X-ray
department or for surveillance. Medical instructions have to
be explained more intensively to the patients. Shortening
the hospital stay may need more medical instructions and
organization time to reduce the patients’ fear and insecurity.
Ferri et al. found in a study of clinical pathways in
foregut surgery that 95% of all patients were satisfied with
their nursing care [37]. In this study, patient satisfaction
was not specifically analyzed, but patient satisfaction, as
regularly measured in the department, was not altered
during the study period.
Would a randomized cost study be better to establish the
value of clinical pathways? This would only be possible if
patients could be allotted to independent units and if nurses
and doctors would not switch between them. Otherwise, the
influence of clinical pathways could not be withheld from
confounding the control group. Consequently, we chose a
cohort study methodology using a control group of patients
treated just prior to the introduction of the clinical path-
ways. This “before-after” methodology is used in most
trials as has been recently shown in a review article by
Ronellenfitsch et al. [16]. We also included a 2-month
“learning” phase with the clinical pathways to optimize
their use. The methodology, however, does not account for
possible secular trends that lead to a general reduction of
hospital stay without the intervention of clinical pathways
as has been found in a study by Dy et al. [38] in 2003.
Contrariwise, before, during, and after the study period,
overall mean hospital stay per patient in the department
increased: 7.7 days (2004), 7.7 days (2005), 8.4 days
(2006), and 8.5 days (2007). Additionally, clinical path-
ways have proven to reduce costs beyond secular trends as
has been shown in a recent study by Vanounou et al. [39].
The proportion of costs savings is a function of
percentage of procedures that can be standardized by
clinical pathways and the mean saving per procedure. In a
surgical department, not all procedures can be standardized,
but the main workload consists of general surgical
procedures. If we extrapolate from the data of this study
to the general surgical department, we believe the total
saving per department could exceed 20%. This extrapola-
tion does not take into account the fact that, with a shorter
hospital stay, even more patients could be treated in the
same period allowing for a higher patient turnover.
In conclusion, this study demonstrates a dramatic impact
of clinical pathways on hospital stay and costs, while
patients’ safety remains unaffected. Additionally, the
pattern of nursing activities shifted towards more time for
a dialogue with the patient. Therefore, clinical pathways
should become routine in all hospitals as medical resource
utilization can be optimized and costs can be significantly
lowered.
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